TNF and COVID-19: Moreover, patients with COVID-19 had significantly less central and effector memory CD4 T-cell subsets capable of IFNγ and TNFα co-expression in response to a polyclonal in vitro stimulation with PMA/Ionomycin mixture in comparison with the controls and COVID-19 convalescents.